Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-20

Clinical Trial Update: B6 Administration for Levetiracetam-Associated Neurobehavioral Changes and Epilepsy [NA]

View source ↗

Summary

A clinical trial is evaluating the use of vitamin B6 (pyridoxine) administration for Levetiracetam-associated neurobehavioral changes and epilepsy in brain tumo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)
  • Pyridoxine (Pyridoxine)

Snippet

Sponsor: Duke University | Conditions: Brain Tumor Related Epilepsy (BTRE) | NA | Status: NOT_YET_RECRUITING